Combining Cognitive Therapies (Cognitive Behavior Therapy & Cognitive Remediation Therapy) for Psychosis: Scientific Rationale and Possibilities

Opinion

Austin J Psychiatry Behav Sci. 2016; 3(1): 1050.

Combining Cognitive Therapies (Cognitive Behavior Therapy & Cognitive Remediation Therapy) for Psychosis: Scientific Rationale and Possibilities

Naeem F1,2*, Hirji A1 and Rathod S3

¹Department of Psychiatry, Queens University, Canada

²Addiction & Mental Health Services-Kingston, Frontenac, Lennox & Addington, Kingston, Canada

³Southern Health NHS Foundation Trust, Southampton, UK

*Corresponding author: Naeem F, Addiction & Mental Health Services-Kingston, Frontenac, Lennox & Addington, Kingston, 385 Princess Street, Kingston, ON, K7L 1B9, UK

Received: March 07, 2016; Accepted: April 31, 2016; Published: May 04, 2016

Cognitive Behaviour Therapy for psychosis (CBTp)

Introduction

Cognitive Behavioural Therapy for psychosis (CBTp) is a flexible psychotherapeutic intervention that has been adapted to be delivered in inpatient and outpatient settings, in the group and individual formats, as a briefer and longer-term intervention, in the acute and residual phases of illness, and by less experienced clinicians [1]. Given the trend towards developing adjunctive treatments for psychotic disorders in recent years, Cognitive Behavioural Therapy for psychosis (CBTp) is becoming increasingly popular. CBTp is typically an integrated approach that contains various components, including psychosocial education about the illness, goal setting, symptom monitoring, cognitive restructuring, skills training, and homework assignments. With CBTp’s growing popularity, many meta-analytic reviews of RCTs have been conducted, many of which established the safety and efficacy of CBTp [1,2].

Evidence for the effectiveness

With the growing attention towards producing methodologically rigorous research, results from recent meta-analyses examining CBTp are not as optimistic [3] conducted a meta-analytic review of 34 CBTp studies and found overall beneficial effects for the target symptom (ES = 0.40, 95% CI [0.252, 0.548]) as well as significant effects for negative symptoms, functioning, mood, and social anxiety with effects ranging from 0.35 to 0.44, suggesting a moderate effect. However, these researchers also examined methodological variables responsible for the inflation of effect sizes and found that lack of participant masking was responsible for an inflated effect size of approximately 50% - 100%. After taking participant masking into consideration, they found the rigorous CBTp studies to have a small effect size for the target symptom (ES = 0.22, 95% CI [0.017, 0.428]), and found no significant effect sizes for secondary variables (i.e. negative symptoms).

In a recent meta-analytic study, [4] analysed 34 studies to examine the pooled effect size for overall symptoms, positive symptoms, and negative symptoms. They found a pooled effect size of -0.33 (95% CI [-0.47, -0.19]) for overall symptoms, -0.25 (95% CI [-0.37, -0.13]) for positive symptoms, and -0.13 (95% CI [-0.25, -0.01]) for negative symptoms. However, similar to [3], these researchers took into consideration potential biases within a study, specifically allocation concealment, sequence generation and incompleteness of outcome data. After removing studies with a high risk of bias from the analysis, they found a pooled effect size of -0.15 (95% CI [-0.32, -0.01]) for overall symptoms, -0.10 (95% CI [-0.28, -0.09]) for positive symptoms, and -0.02 (95% CI [-0.15, -0.11]) for negative symptoms.

Overall, these studies suggest that CBTp has a therapeutic effect on schizophrenia in the small to moderate range. However, when controlling for potential sources of bias and examining methodologically sound research, these effect sizes further reduce. So far there is no report of the effectiveness of CBTp on cognitive functions.

How it works

CBT was first applied to schizophrenia in a single case study by Beck in 1952 [5]. Since then, CBTp has developed from the traditional model of CBT for depression while also incorporating cognitive theory and interventions for anxiety disorders. Normalization is an important component of the CBTp [6].

When CBTp first came about, it was believed that positive symptoms of schizophrenia (i.e. hallucinations and delusions) lay outside the realms of normal psychological functioning and, therefore, could only be treated by pharmaceutical interventions. As such, CBTp in its earliest form relied primarily on behavioural strategies, such as graded activity programs, to improve coping, build social and independent living skills, and increase compliance to medication. Although these approaches continue to be utilized when negative symptoms and functional outcomes are the main focus of intervention, over the year’s changes in how positive symptoms were conceptualized led to the incorporation of cognitive therapy and techniques into CBTp.

Over the years, it became widely recognized that normal psychological processes are applicable to psychotic symptoms, and could, therefore, be amendable with cognitive theory. Cognitive models outline the role of faulty beliefs, increased attention to threatrelated stimuli, biased information processing of confirmatory evidence, and safety behaviors (i.e. avoidance of specific situations) in the experience of hallucinations and delusions [7]. Additionally, it is believed that the distress is the result of the individual’s personal meaning, understanding, and coping of the experience, rather than the experience itself. Thus, CBTp attempts to alter cognitive biases by addressing the content of thoughts and styles of thinking.

Despite the theoretical similarities between CBTp and CBT for non-psychotic disorders, there are some key differences. In CBTp (Table 1) sessions are often shorter in duration and more flexible, and the homework is often simplified, in order to adapt to the cognitive functioning of this population. Additionally, stigma is often addressed by normalizing some of the negative beliefs and assumptions people have about schizophrenia, and to instill more optimistic perspectives by providing alternative explanations [7]. Finally, based on research implicating sleep disturbances, affect, and safety behaviors in positive symptoms, these behaviors are important targets for CBTp [7].

Citation: Naeem F, Hirji A and Rathod S. Combining Cognitive Therapies (Cognitive Behavior Therapy & Cognitive Remediation Therapy) for Psychosis: Scientific Rationale and Possibilities. Austin J Psychiatry Behav Sci. 2016; 3(1): 1050. ISSN : 2381-9006